COVID-19 vaccine trials: The potential for "hybrid" analyses.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 391, doi. 10.1177/17407745211018613
- By:
- Publication type:
- Article
Works matching IS 17407745 AND DT 2021 AND VI 18 AND IP 4
Results: 15
1
2
Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations?: Experiences from a study of anti-depressants in healthy volunteers.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 505, doi. 10.1177/17407745211012683
- By:
- Publication type:
- Article
3
Assessing the external validity of the VALIDATE-SWEDEHEART trial.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 427, doi. 10.1177/17407745211012438
- By:
- Publication type:
- Article
4
A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- Letter
5
Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 477, doi. 10.1177/17407745211011069
- By:
- Publication type:
- Article
6
Strategies for research participant engagement: A synthetic review and conceptual framework.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 457, doi. 10.1177/17407745211011068
- By:
- Publication type:
- Article
7
Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 417, doi. 10.1177/17407745211010139
- By:
- Publication type:
- Article
8
Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 408, doi. 10.1177/17407745211009547
- By:
- Publication type:
- Article
9
Randomized comparison of two interventions to enhance understanding during the informed consent process for research.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 466, doi. 10.1177/17407745211009529
- By:
- Publication type:
- Article
10
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 500, doi. 10.1177/17407745211005045
- By:
- Publication type:
- Article
11
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 488, doi. 10.1177/17407745211005044
- By:
- Publication type:
- Article
12
The triple aim of clinical research.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 511, doi. 10.1177/17407745211001522
- By:
- Publication type:
- Article
13
Strategies for facilitating the delivery of cluster randomized trials in hospitals: A study informed by the CFIR-ERIC matching tool.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 398, doi. 10.1177/17407745211001504
- By:
- Publication type:
- Article
14
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 449, doi. 10.1177/1740774520988838
- By:
- Publication type:
- Article
15
Effectiveness of participant recruitment strategies for critical care trials: A systematic review and narrative synthesis.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 436, doi. 10.1177/1740774520988678
- By:
- Publication type:
- Article